{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:31:42Z","timestamp":1792402302580,"version":"4.4.0"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Pharmaceutical Design"],"published-print":{"date-parts":[[2011,4,1]]},"DOI":"10.2174\/138161211795589373","type":"journal-article","created":{"date-parts":[[2011,5,9]],"date-time":"2011-05-09T07:07:19Z","timestamp":1304924839000},"page":"1040-1044","source":"Crossref","is-referenced-by-count":51,"title":["NAP (Davunetide) Provides Functional and Structural Neuroprotection"],"prefix":"10.2174","volume":"17","author":[{"given":"Illana","family":"Gozes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/74017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,20]],"date-time":"2015-11-20T08:58:11Z","timestamp":1448009891000},"score":1,"resource":{"primary":{"URL":"http:\/\/openurl.ingenta.com\/content\/xref?genre=article&issn=1381-6128&volume=17&issue=10&spage=1040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,1]]},"references-count":0,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,4,1]]}},"alternative-id":["1381-6128(20110401)17:10L.1040;1-"],"URL":"https:\/\/doi.org\/10.2174\/138161211795589373","relation":{},"ISSN":["1381-6128"],"issn-type":[{"value":"1381-6128","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4,1]]}}}